Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United States”

Cooperative Assessment of Late Effects for SCD Curative TherapiesRecruiting
NCT05153967N/AUpdated Jul 27, 2026
Sponsor: Vanderbilt University Medical Center
Sickle Cell Disease · Pulmonary Disease · Renal Disease · Heart Disease
United States
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseRecruiting
NCT06830629Phase 2Updated Jul 27, 2026
Sponsor: Maze Therapeutics
Proteinuric Kidney Disease
United States, France, United Kingdom
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus ErythematosusRecruiting
NCT07260877Phase 2Updated Jul 27, 2026
Sponsor: Ventus Therapeutics U.S., Inc.
Cutaneous Lupus Erythematosus (CLE) · Systemic Lupus Erythematosus · SLE · SLE (Systemic Lupus)
United States, Bulgaria, France, Georgia, Hungary +3 more
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)Enrolling By Invitation
NCT06280820N/AUpdated Jul 27, 2026
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Heart Failure
United States
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung CancerRecruiting
NCT07155174Phase 2Updated Jul 27, 2026
Sponsor: AbbVie
Small Cell Lung Cancer
United States, Belgium, China, Germany, Israel +7 more
MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)Recruiting
NCT07244211NAUpdated Jul 27, 2026
Sponsor: University of Southern California
Femoral Neck Fractures
United States, Canada, Spain, United Kingdom
Chemotherapy With or Without Immunotherapy for Peritoneal MesotheliomaRecruiting
NCT05001880Phase 2Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Peritoneal Malignant Mesothelioma
United States
Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell TherapyCompleted
NCT04975555Phase 2Updated Jul 27, 2026
Sponsor: University of Alabama at Birmingham
Cytokine Release Syndrome · ICANS · Lymphoma, Non-Hodgkin · Multiple Myeloma
United States
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic MigraineNot Yet Recruiting
NCT07729462Phase 3Updated Jul 27, 2026
Sponsor: Pfizer
Preventive Treatment of Migraine
United States
Plan and Protect: Safety Planning for Teens in Rural Emergency DepartmentsNot Yet Recruiting
NCT07325474NAUpdated Jul 27, 2026
Sponsor: Dartmouth-Hitchcock Medical Center
Suicide Ideation · Suicide Attempt
United States
Visual Aids for Induction of Labor RCTCompleted
NCT05671224NAUpdated Jul 27, 2026
Sponsor: Washington University School of Medicine
Induced; Birth
United States
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Recruiting
NCT06966700Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms · Triple Negative Breast Neoplasms · HR Low-Positive/HER2-Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +34 more
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast CancerRecruiting
NCT07205822Phase 3Updated Jul 27, 2026
Sponsor: AstraZeneca
Breast Cancer
United States, China, France, Italy, South Korea +1 more
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical CarcinomaRecruiting
NCT06487481Phase 1Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Adrenocortical Carcinoma (ACC) · Recurrent Adrenocortical Carcinoma (ACC) · Recurrent Abdominal Adrenocortical Carcinoma (ACC) · Carcinoma, Adrenocortical
United States
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial AneurysmsRecruiting
NCT07143019NAUpdated Jul 27, 2026
Sponsor: phenox Inc.
Hemorrhagic Stroke · Aneurysm, Intracranial · Saccular Aneurysm · Fusiform Aneurysm
United States
Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and AdultsNot Yet Recruiting
NCT07388537N/AUpdated Jul 27, 2026
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Obesity · Diabetes · Metabolic Disorders
United States
Observational Study of Advanced Data Analytics in Genetic ConditionsRecruiting
NCT05657405N/AUpdated Jul 27, 2026
Sponsor: National Human Genome Research Institute (NHGRI)
Genetic Conditions
United States
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesActive Not Recruiting
NCT05753501Phase 1Updated Jul 27, 2026
Sponsor: AbbVie
Hematologic Cancer
United States, Canada, France, Germany, Israel +4 more
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)Recruiting
NCT07513376Phase 3Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Australia, Canada, Germany, Greece +8 more
An Open-Label, Two-Cohort, Pharmacokinetic Study in a Maximal Use Setting for Patients With Actinic Keratosis on the Upper Extremities or the FaceRecruiting
NCT07729579Phase 1Updated Jul 27, 2026
Sponsor: Sun Pharmaceutical Industries Limited
Actinic Keratosis (AK)
United States
e-HERO: Ending the HIV Epidemic in Rural OklahomaCompleted
NCT05664802NAUpdated Jul 27, 2026
Sponsor: Northern Arizona University
Human Immunodeficiency Virus (HIV)
United States
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus ErythematosusActive Not Recruiting
NCT05531565Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Biogen
Subacute Cutaneous Lupus Erythematosus · Chronic Cutaneous Lupus Erythematosus
United States, Argentina, Belgium, Brazil, Bulgaria +25 more
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial FibrillationActive Not Recruiting
NCT06096337NAUpdated Jul 27, 2026
Sponsor: Boston Scientific Corporation
Persistent Atrial Fibrillation
United States, Australia, Austria, Belgium, Canada +8 more
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentRecruiting
NCT06589804Phase 3Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Metastatic Head and Neck Squamous Cell Carcinoma · Metastatic Hypopharyngeal Squamous Cell Carcinoma · Metastatic Laryngeal Squamous Cell Carcinoma · Metastatic Oral Cavity Squamous Cell Carcinoma
United States
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical CancerRecruiting
NCT05838521Phase 2Updated Jul 27, 2026
Sponsor: Yale University
Cervical Cancer
United States

Previous page Next page